Significant Changes to ESRD Drug Add-On Pricing and Quality Measures

This evening, the Centers for Medicare and Medicaid Services (CMS) released the CY 2019 final payment rule for the End-Stage Renal Disease (ESRD) program. The rule contains a payment update for the ESRD Prospective Payment System, changes to the ESRD quality program, and an expansion of the ESRD Transitional Drug Add-on Payment Adjustment (TDAPA). Additionally, the [...] Read More